title: 2-Hydroxy-4-glutathion-S-yl-17beta-estradiol and 2-hydroxy-1-glutathion-S-yl-17beta-estradiol produce oxidative stress and renal toxicity in an animal model of 17beta-estradiol-mediated nephrocarcinogenicity.
abstract: Chronic exposure of male Syrian hamsters to a variety of estrogens has been linked with a high incidence of renal carcinoma. The basis of this species and tissue specificity remains to be resolved. We have recently shown that (i) 17beta-estradiol is nephrotoxic in the hamster in a manner dependent upon the activity of gamma-glutamyl transpeptidase and (ii) 17beta-estradiol is metabolized to a variety of catechol estrogen glutathione conjugates (Butterworth et al., Carcinogenesis, 18, 561-567, 1997). We report that the catechol estrogen glutathione conjugates exhibit redox properties similar to those of the catechol estrogens, and maintain the ability to generate superoxide radicals. Administration of 2-hydroxy-4-glutathion-S-yl-17beta-estradiol or 2-hydroxy-1-glutathion-S-yl-17beta-estradiol (0.27-5.0 micromol/kg) to Syrian hamsters, produces mild nephrotoxicity. Repeated daily administration of 2-hydroxy-4-glutathion-S-yl-17beta-estradiol causes a sustained elevation in urinary markers of renal damage and in the concentration of renal protein carbonyls and lipid hydroperoxides. Catechol estrogen oxidation and conjugation of glutathione in the liver, followed by the selective uptake of the redox active conjugates in tissues rich in gamma-glutamyl transpeptidase may contribute to 17beta-estradiol-induced renal tumors in the hamster.
authors.affiliation: Division of Pharmacology and Toxicology, College of Pharmacy, University of Texas at Austin, 78712, USA.
authors.forename: M
authors.initials: M
authors.lastname: Butterworth
authors.forename: S S
authors.initials: SS
authors.lastname: Lau
authors.forename: T J
authors.initials: TJ
authors.lastname: Monks
mesh_terms: D000818:Animals; D002273:Carcinogens / Q000633:toxicity*; D006224:Cricetinae; D004847:Epithelial Cells / Q000187:drug effects / Q000473:pathology; D004958:Estradiol / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000633:toxicity*; D005978:Glutathione / Q000031:analogs & derivatives* / Q000633:toxicity; D007668:Kidney / Q000187:drug effects / Q000473:pathology* / Q000502:physiology; D007679:Kidney Medulla / Q000187:drug effects / Q000473:pathology; D007680:Kidney Neoplasms / Q000139:chemically induced*; D007687:Kidney Tubules, Proximal / Q000187:drug effects / Q000473:pathology; D008297:Male; D008647:Mesocricetus; D018384:Oxidative Stress; D013481:Superoxides / Q000378:metabolism
chemical_list: C110519:2-hydroxy-4-glutathion-S-yl-17 beta-estradiol; D002273:Carcinogens; D013481:Superoxides; D004958:Estradiol; D005978:Glutathione